Notably, Sauer et al. (34) reported the first structure of human sodium-dependent citrate transporter NaCT and revealed the substrate and inhibitor bound inward facing conformation, providing an important clue to optimize the anti-obesity drugs. Here, SLC13A5 is linked to obesity disorder.